EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 3.0

Mild Hypertransaminasemia in Primary Care

Said A Al-Busafi, Nir Hilzenrat

ISRN Hepatology · 2013

DOI: 10.1155/2013/256426 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ISRN Hepatology, 2013. Verfasst von Said A Al-Busafi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, College of Medicine and Health Science, Sultan Qaboos University, P.O. Box 35, 123 Muscat, Oman; Department of Gastroenterolo…. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The liver enzymes, alanine transaminase (ALT) or aspartate transaminase (AST), are commonly used in clinical practice as screening as well as diagnostic tests for liver diseases. ALT is more specific for liver injury than AST and has been shown to be a good predictor of liver related and all-cause mortality. Asymptomatic mild hypertransaminasemia (i.e., less than five times normal) is a common finding in primary care and this could be attributed to serious underlying condition or has transient and benign cause. Unfortunately, there are no good literatures available on the cost-effectiveness of evaluating patients with asymptomatic mild hypertransaminasemia. However, if the history and physical examination do not suggest a clear cause, a stepwise approach should be initiated based on pretest probability of the underlying liver disease. Nonalcoholic fatty liver disease is becoming the most common cause of mild hypertransaminasemia worldwide. Other causes include alcohol abuse, medications, and hepatitis B and C. Less common causes include hemochromatosis, α 1-antitrypsin deficiency, autoimmune hepatitis, and Wilson's disease. Nonhepatic causes such as celiac disease, thyroid, and muscle disorders should be considered in the differential diagnosis. Referral to a specialist and a possible liver biopsy should be considered if persistent hypertransaminasemia for six months or more of unclear etiology.

Autor:innen und Institutionen

  • Department of Medicine, College of Medicine and Health Science, Sultan Qaboos University, P.O. Box 35, 123 Muscat, Oman; Department of Gastroenterology, Jewish General Hospital, McGill University, Montreal, QC, Canada H…
  • Department of Gastroenterology, Jewish General Hospital, McGill University, Montreal, QC, Canada H3T 1E2.

Zitieren

APA

Al-Busafi, S. A., & Hilzenrat, N. (2013). Mild Hypertransaminasemia in Primary Care. ISRN Hepatology. https://doi.org/10.1155/2013/256426

Vancouver

Al-Busafi SA, Hilzenrat N. Mild Hypertransaminasemia in Primary Care. ISRN Hepatology. 2013. doi:10.1155/2013/256426

BibTeX
@article{AlBusafi2013,
  author = {Al-Busafi, Said A and Hilzenrat, Nir},
  title = {Mild Hypertransaminasemia in Primary Care},
  journal = {ISRN Hepatology},
  year = {2013},
  doi = {10.1155/2013/256426}
}
Kostenlos starten →